USPTO serial 88257580
ZYMERON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 23, 2019
- Examiner
- HOPKINS II, DEAN ANDREW
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with ZYMERON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Product research and development; scientific research and development; biochemical research and development; pharmaceutical research and development; research and development of new products; research and development of new products for others; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of antibodies; research and development of new products for third parties in the fields of plastic materials; research and development of technology and products in the fields of nanomaterials, polymer materials, polymer-based biomaterials, biopolymers, in vitro diagnostics tests, sample collection techniques and devices, drug delivery formulations, pharmaceutical dose forms, pharmaceutical devices, drug formulations, dermatological products, biological drugs, immunotherapy agents, protein purification materials and agents, coatings, and medical devices; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic sciences, laboratory testing, diagnostics, and pharmacogenetics; consulting services in the fields of nanomaterials, polymer materials, polymer-based biomaterials, biopolymers, in vitro diagnostics tests, sample collection techniques and devices, drug delivery formulations, pharmaceutical dose forms, pharmaceutical devices, drug formulations, dermatological products, biological drugs, immunotherapy agents, protein purification materials and agents, coatings, and medical devices; research and development in the fields of nanomaterials, polymer materials, polymer-based biomaterials, biopolymers, in vitro diagnostics tests, sample collection techniques and devices, drug delivery formulations, pharmaceutical dose forms, pharmaceutical devices, drug formulations, dermatological products, biological drugs, immunotherapy agents, protein purification materials and agents, coatings, and medical devices; design, engineering, research, development, and testing services in the field of polymeric materials, polymers synthesis, and materials customization for medical, scientific, and technological applications | ACTIVE | Jan 6, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 9, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 9, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 6, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 3, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jul 23, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 23, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 7, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 7, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 17, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 26, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 1, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 14, 2019 | NWAP | NEW APPLICATION ENTERED | — |